Research Stories

Injecting common painkiller an alternative to heroin, Vancouver study finds

Offering a legal painkiller to chronic heroin addicts can help them stop using street drugs and reduce the crime that goes along with it, concludes a Vancouver-based study released Wednesday.

Vancouver researchers find pain medication can work as treatment for severe heroin addiction

Since November 2014, a small group of Vancouver doctors has administered prescription heroin as a treatment for severe addiction to opioids.

Pain medication can be used to treat severe heroin addicts: Vancouver study

For nine years, Max’s life spiralled out of control as a heroin addiction following a car crash had him living on the streets, barely eating and constantly hungering for his next fix.

Vancouver study finds possible new treatment path for heroin addiction

People with chronic heroin addiction may soon have another treatment option after the conclusion of a groundbreaking study in Vancouver’s Downtown Eastside.

Opioid Painkiller May Be New Treatment for Heroin Addicts

Hydromorphone — an opioid painkiller — may be another treatment option for heroin addiction, a new Canadian study suggests.

Heroin nearly killed me but pain med saved me: Max

A groundbreaking study conducted on Vancouver's Downtown Eastside has found hydromorphine could be beneficial to drug addicts trying to turn their lives around.

Vancouver research spots Alzheimer’s early (St.Paul's Hospital)

With a bigger share of Canadians than ever aging into their golden years, questions about how to diagnose and treat dementia are becoming more pressing.

St. Paul’s develops a more reliable Alzheimer’s test

Mario Gregorio will sometimes go to heat a cup of water for tea only to find there’s a cup already in the microwave.

Human trials to be conducted on new Alzheimer’s test (St. Paul's Hospital)

Doctors at Vancouver’s St. Paul’s Hospital are working on a better way to figure out if a person has dementia, and what type it is. Linda Aylesworth reports.
 

B.C. government allocates $50 million for health research

The MSFHR has developed advances in breast cancer, human papillomavirus, and researches ways to prevent falls. The foundation is currently funnelling money into the Men’s Health Research Program which helps men deal with depression and suicide.

New drug trial to improve stroke care (PHCRI)

BC Emergency Health Services is participating in a drug trial to determine if NA-1, a neuroprotectant designed to contain the damage to the brain in the event of a stroke, is effective in reducing disability in patients with acute cerebral ischemia if administered early after symptom onset. Paramedics in Vancouver and Richmond, BC, and Toronto and Peel, ON, will be administering the clinical study drug.

Suboxone added to Pharmacare (BC Centre for Excellence in HIV/AIDS)

In an effort to address what it calls a “prescription opioid epidemic” in the province, the Ministry of Health has added Suboxone to PharmaCare coverage.

Canadian Researchers Receive Over $750,000 to Further HIV and AIDS Discover

Today the Canadian Foundation for AIDS Research (CANFAR) announced their grant allocations for HIV and AIDS research that will help us better understand the virus and work to ultimately end AIDS. As the largest charitable funder of HIV research in Canada, CANFAR is providing $765,000 to fund innovative Canadian studies that are impacting the lives of Canadians and millions of people globally. The past 30 years have seen incredible research advancements, and now is the time for Canadians to support and push forward in hopes of creating an AIDS-free future.
 

HIV rates in vulnerable men to be studied with $6.5M grant (Dr. Robert Hogg, BC Centre for Excellence in HIV/AIDS)

A SFU researcher is receiving a $6.5 million grant for his study on HIV rates among men who have sex with men. 

SFU researcher awarded grant to study HIV among vulnerable populations (Dr. Robert Hogg)

SFU health sciences researcher Robert Hogg has been awarded a $6.5-million grant to identify ongoing health inequities among vulnerable HIV-positive populations in B.C. and the rest of Canada.

Expanding Access to HAART Saves Millions in Health Care and Productivity Costs (Dr. Julio Montaner, BC-CfE)

A study published in The Lancet HIV by the BC Centre for Excellence in HIV/AIDS (BC-CfE) shows expanding Treatment as Prevention® (TasP®) could save up to $66.5 million over the next 25 years, compared with a scenario with reduced access to antiretroviral medication. The study finds expanded access to highly active antiretroviral therapy (HAART) has more than offset the additional costs of treatment, resulting in improved health outcomes and cost-savings.

 

Pages